Simultaneous measurement of insulin sensitivity, insulin secretion, and the disposition index in conscious unhandled mice

Obesity

Volumn 20, Issue 7, 2012, Pages 1403-1412

  Alonso, Laura C ^a   Watanabe, Yoshio ^a   Stefanovski, Darko ^b   Lee, Euhan J ^a   Singamsetty, Srikanth ^a   Romano, Lia C ^a   Zou, Baobo ^a   Garcia Ocãa, Adolfo ^a   Bergman, Richard N ^b   O'Donnell, Christopher P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; DISPOSITION INDEX; FREQUENTLY SAMPLED INTRAVENOUS GLUCOSE TOLERANCE TEST; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LEAN BODY WEIGHT; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; OBESITY; VALIDATION PROCESS;

ANIMALS; BLOOD GLUCOSE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS;

MURINAE; MUS;

EID: 84862847419     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.36     Document Type: Article

References (45)

1. Berglund ED, Li CY, Poffenberger G et al. Glucose metabolism in vivo in four commonly used inbred mouse strains. Diabetes 2008;57:1790-1799.
2. Kim JK, Zisman A, Fillmore JJ et al. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin Invest 2001;108:153-160.
3. Kulkarni RN, Almind K, Goren HJ et al. Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice. Diabetes 2003;52: 1528-1534.
4. Lillioja S, Mott DM, Spraul M et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993;329:1988-1992.
5. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-794.
6. Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 2001;24:89-94.
7. Bergman RN, Finegood DT, Kahn SE. The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 2002;32(Suppl 3):35-45.
8. Chen M, Bergman RN, Pacini G, Porte D Jr. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. J Clin Endocrinol Metab 1985;60:13-20.
9. Ayala JE, Samuel VT, Morton GJ et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech 2010;3:525-534.
10. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985;6:45-86.
11. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456-1467.
12. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987;79:790-800.
13. Lorenzo C, Wagenknecht LE, Rewers MJ et al. Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010;33: 2098-2103.
14. Lyssenko V, Jonsson A, Almgren P et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008;359:2220-2232.
15. Kahn SE, Prigeon RL, McCulloch DK et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-1672.
16. Pacini G, Thomaseth K, Ahrén B. Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. Am J Physiol Endocrinol Metab 2001;281:E693-E703.
17. McArthur MD, You D, Klapstein K, Finegood DT. Glucose effectiveness is the major determinant of intravenous glucose tolerance in the rat. Am J Physiol 1999;276:E739-E746.
18. Alonso LC, Yokoe T, Zhang P et al. Glucose infusion in mice: a new model to induce beta-cell replication. Diabetes 2007;56:1792-1801.
19. Yokoe T, Alonso LC, Romano LC et al. Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol (Lond) 2008;586:899-911.
20. Rowland NE, Dunn AJ. Effect of dexfenfluramine on metabolic and neurochemical measures in restraint-stressed ob/ob mice. Physiol Behav 1995;58:749-754.
21. Iiyori N, Alonso LC, Li J et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 2007;175:851-857.
22. Pacini G, Ahrén M, Ahrén B. Reappraisal of the intravenous glucose tolerance index for a simple assessment of insulin sensitivity in mice. Am J Physiol Regul Integr Comp Physiol 2009;296:R1316-R1324.
23. Toye AA, Lippiat JD, Proks P et al. A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice. Diabetologia 2005;48:675-686.
24. Freeman HC, Hugill A, Dear NT, Ashcroft FM, Cox RD. Deletion of nicotinamide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes 2006;55:2153-2156.
25. Wong N, Blair AR, Morahan G, Andrikopoulos S. The deletion variant of nicotinamide nucleotide transhydrogenase (Nnt) does not affect insulin secretion or glucose tolerance. Endocrinology 2010;151:96-102.
26. Curry DL, Bennett LL, Grodsky GM. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 1968;83:572-584.
27. Maechler P, Gjinovci A, Wollheim CB. Implication of glutamate in the kinetics of insulin secretion in rat and mouse perfused pancreas. Diabetes 2002;51(Suppl 1):S99-102.
28. Nunemaker CS, Wasserman DH, McGuinness OP et al. Insulin secretion in the conscious mouse is biphasic and pulsatile. Am J Physiol Endocrinol Metab 2006;290:E523-E529.
29. Prehn RT. Nongenetic variability in susceptibility to oncogenesis. Science 1975;190:1095-1096.
30. Jakovcevski M, Schachner M, Morellini F. Individual variability in the stress response of C57BL/6J male mice correlates with trait anxiety. Genes Brain Behav 2008;7:235-243.
31. Zhang LN, Morgan DG, Clapham JC, Speakman JR. Factors predicting nongenetic variability in body weight gain induced by a high-fat diet in inbred C57BL/6J mice. Obesity (Silver Spring) 2011; e-pub ahead of print 30 June 2011.
32. Vedell PT, Svenson KL, Churchill GA. Stochastic variation of transcript abundance in C57BL/6J mice. BMC Genomics 2011;12:167.
33. Watkins-Chow DE, Pavan WJ. Genomic copy number and expression variation within the C57BL/6J inbred mouse strain. Genome Res 2008;18:60-66.
34. Tanaka T, Nabatame H, Tanifuji Y. Insulin secretion and glucose utilization are impaired under general anesthesia with sevoflurane as well as isoflurane in a concentration-independent manner. J Anesth 2005;19:277-281.
35. Schlosser S, Spanholtz T, Merz K et al. The choice of anesthesia influences oxidative energy metabolism and tissue survival in critically ischemic murine skin. J Surg Res 2010;162:308-313.
36. Johansen O, Vaaler S, Jorde R, Reikerås O. Increased plasma glucose levels after Hypnorm anaesthesia, but not after Pentobarbital anaesthesia in rats. Lab Anim 1994;28:244-248.
37. Filipsson K, Pacini G, Scheurink AJ, Ahrén B. PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice. Am J Physiol 1998;274:E834-E842.
38. Ahrén B, Pacini G. Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice. Am J Physiol 1999;277: E996-E1004.
39. Aston-Mourney K, Wong N, Kebede M et al. Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes. Diabetologia 2007;50: 2476-2485.
40. Kooptiwut S, Zraika S, Thorburn AW et al. Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure. Endocrinology 2002;143:2085-2092.
41. Ayala JE, Bracy DP, McGuinness OP, Wasserman DH. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 2006;55:390-397.
42. Taniguchi A, Fukushima M, Sakai M et al. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance. Diabetes Care 2000;23:127-128.
43. Goldfine AB, Bouche C, Parker RA et al. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci USA 2003;100:2724-2729.
44. Osei K, Rhinesmith S, Gaillard T, Schuster D. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 2004;27:1439-1446.
45. Martin BC, Warram JH, Krolewski AS et al. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992;340:925-929.